- Home
- GAME vs RVPH Comparison
GAME vs RVPH Comparison
Compare GAME & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- RVPH
- Stock Information
- Founded
- GAME 2011
- RVPH 2006
- Country
- GAME United States
- RVPH United States
- Employees
- GAME N/A
- RVPH N/A
- Industry
- GAME
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- GAME
- RVPH Health Care
- Exchange
- GAME Nasdaq
- RVPH Nasdaq
- Market Cap
- GAME 74.8M
- RVPH 26.6M
- IPO Year
- GAME 2009
- RVPH N/A
- Fundamental
- Price
- GAME $0.95
- RVPH $0.46
- Analyst Decision
- GAME Strong Buy
- RVPH Strong Buy
- Analyst Count
- GAME 3
- RVPH 5
- Target Price
- GAME $3.67
- RVPH $9.00
- AVG Volume (30 Days)
- GAME 25.6M
- RVPH 3.2M
- Earning Date
- GAME 08-13-2025
- RVPH 08-13-2025
- Dividend Yield
- GAME N/A
- RVPH N/A
- EPS Growth
- GAME N/A
- RVPH N/A
- EPS
- GAME N/A
- RVPH N/A
- Revenue
- GAME $99,579,536.00
- RVPH N/A
- Revenue This Year
- GAME $6.08
- RVPH N/A
- Revenue Next Year
- GAME $21.94
- RVPH N/A
- P/E Ratio
- GAME N/A
- RVPH N/A
- Revenue Growth
- GAME 77.06
- RVPH N/A
- 52 Week Low
- GAME $0.50
- RVPH $0.30
- 52 Week High
- GAME $2.87
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- GAME 42.59
- RVPH 46.82
- Support Level
- GAME $1.47
- RVPH $0.44
- Resistance Level
- GAME $1.24
- RVPH $0.53
- Average True Range (ATR)
- GAME 0.26
- RVPH 0.04
- MACD
- GAME -0.10
- RVPH 0.02
- Stochastic Oscillator
- GAME 0.02
- RVPH 56.07
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.